INTEGRATED CANCER CARE · VANCOUVER, BC, CANADA
Monday–Friday 9–5   |   604-428-1991
31 October 2024 · LEMMO Cancer Care research & perspectives

Topical NSAID Prevents Skin Side-Effect (Hand Foot Syndrome) From Oral Chemo Pill (Xeloda)

The use of NSAIDs helps reduce the risks of the troubling and at times painful Hand-Foot Syndrome in patients using the oral chemo pill Capecitabine (also know as Xeloda). In particular the topical NSAID – Diclofenac Gel was used in this study, where others have also used Celebrex orally with success as well. The topical option worked very well and appeared to be well tolerated on the body. As a result less treatment interruptions due to less raw or painful hands and feet which is a win win. #xeloda #capecitabine #NSAID

Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial

Discuss what this means for you

Research can raise useful questions. A study or individual case report does not establish that a treatment is suitable for everyone. Discuss medications, supplements and treatment changes with your care team.

Talk with our team

Back to all news & research

LEMMO Integrated Cancer Care
We’re here to help

A conversation can
be a beginning.

Have a question about our care or becoming a patient? Our team can explain your first visit and help you take the next step.

Let’s talk about your next step

Send us a message

For appointments and general enquiries. Leave us a message and our team will be in touch.

Call our team
604-428-1991
Email us
info@lemmo.com
Visit our clinic
Suite 205, 3900 Hastings Street
Burnaby, BC V5C 6C1
Office hours
Monday–Friday
9:00 am–5:00 pm
By appointment

Find us in Burnaby

Directions